Metraipolis › archive › dc_8725008ef847

Immunological and Inflammatory Biomarkers in the Prognosis, Prevention, and Treatment of Ischemic Stroke: A Review of a Decade of Advancement — Europe PMC PMID:40869247

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40869247
DOI
10.3390/ijms26167928
License (as archived)
solo-consultazione
Archived
2026-11-10T14:17:29.234Z
SHA-256 of the archived text
12e574e6d2c6208398e994c94561089308db11d0a4e9ef439da90c0e1c4e2f66
Stable URL of this page
https://metraipolis.com/documento/dc_8725008ef847

How to cite

Immunological and Inflammatory Biomarkers in the Prognosis, Prevention, and Treatment of Ischemic Stroke: A Review of a Decade of Advancement — Europe PMC PMID:40869247 — Europe PMC (en), https://europepmc.org/article/MED/40869247 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8725008ef847 (Metraipolis archive dc_8725008ef847, sha256 12e574e6d2c6208398e994c94561089308db11d0a4e9ef439da90c0e1c4e2f66)
BibTeX
@misc{dc8725008ef847,
  title = {Immunological and Inflammatory Biomarkers in the Prognosis, Prevention, and Treatment of Ischemic Stroke: A Review of a Decade of Advancement — Europe PMC PMID:40869247},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40869247},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8725008ef847; sha256 12e574e6d2c6208398e994c94561089308db11d0a4e9ef439da90c0e1c4e2f66},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869247. Agents can read the archived copy with the MCP tool read_document.